MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/nop/npag039

Медицинская библиотека · Neuro-oncology practice · 2026

Automated imaging response evaluation system: Prototype software tool for standardized radiographic response assessment in glioblastoma clinical trials.

Teraishi Ashley, Sanvito Francesco, Raymond Catalina, Cho Nicholas S, Norris Jason, Gandhi Sani, Cohen Alexander R, Hafizka Yashaar, Luo Audrey, Sim Hao-Wen, Wachsmuth Lucas P, Yip Sonia, Koh Eng-Siew, Hall Merryn, Ashley David M, Rosenthal Mark A, Hovey Elizabeth J, Gan Hui K, Johnson Margaret O, Barnes Elizabeth H, Simes John R, Lwin Zarnie, Khasraw Mustafa, Salamon Noriko, Cloughesy Timothy F, Ellingson Benjamin M

СтатьяОбзорПеревод в очереди

Аннотация

The clinical management of patients with brain tumors, as well as the results of clinical trials testing new medications, require the evaluation of tumor changes on MR imaging. After tumor measurements are obtained, the AIRES software application can automatically apply the standardized RANO rules, to ultimately define when the tumor can be considered in a progression phase, as opposed to a stable phase, or in treatment response. This automated tool enables fast, reliable, and reproducible assessments, and therefore has the potential to reduce errors, streamline workflows, and lower costs by minimizing the resources required for training personnel and conducting reads. The standardized Response Assessment in Neuro-Oncology (RANO), modified RANO (mRANO), and RANO 2.0 criteria are utilized for imaging endpoints in glioblastoma clinical trials. After measuring tumor size at each timepoint, the crucial step of categorizing progression, stable disease, and response based on numerical thresholds is currently done manually. "Manual" RANO evaluations are time-consuming, error prone, and require dedicated training. Here, we present the features, installation, and usage of Automated Imaging Response Evaluation System (AIRES), a software application prototype that applies mRANO criteria using externally measured tumor sizes, clinical status, and corticosteroid dose. AIRES labels each timepoint with RANO categories and calculates progression-free survival and objective response rate. As a real-world application on clinical trial datasets, mRANO reads were performed on measurements from 367 brain MRI scans across 41 patients from NUTMEG (NCT04195139), a phase II multicenter clinical trial. Four readers with varying levels of experience achieved a percentage of fully correct RANO reads ranging from 49% to 76%, while AIRES reached 100%, compared to a fifth expert reader. AIRES-based reads were significantly faster than "manual" reads by the expert (37.1 ± 8.6 vs 107.7 ± 58.6 s, P < .0001). AIRES is a reliable and time-efficient tool for mRANO assessments and may be adapted for RANO 2.0.

Для цитирования: Teraishi Ashley, Sanvito Francesco, Raymond Catalina, Cho Nicholas S, Norris Jason, Gandhi Sani, Cohen Alexander R, Hafizka Yashaar, Luo Audrey, Sim Hao-Wen, Wachsmuth Lucas P, Yip Sonia, Koh Eng-Siew, Hall Merryn, Ashley David M, Rosenthal Mark A, Hovey Elizabeth J, Gan Hui K, Johnson Margaret O, Barnes Elizabeth H, Simes John R, Lwin Zarnie, Khasraw Mustafa, Salamon Noriko, Cloughesy Timothy F, Ellingson Benjamin M. Automated imaging response evaluation system: Prototype software tool for standardized radiographic response assessment in glioblastoma clinical trials.. Neuro-oncology practice. 2026. DOI: 10.1093/nop/npag039.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.